154 related articles for article (PubMed ID: 23472518)
1. Mismanagement of malignant hypercalcaemia.
Lightowlers S; Patterson D
Clin Med (Lond); 2013 Feb; 13(1):118. PubMed ID: 23472518
[No Abstract] [Full Text] [Related]
2. [Preclinical and clinical profile of zoledronic acid (Zometa) for hypercalcemia of malignancy].
Tomoo T; Suzuki M
Nihon Yakurigaku Zasshi; 2005 Nov; 126(5):353-7. PubMed ID: 16394581
[No Abstract] [Full Text] [Related]
3. Hypercalcemia of malignancy remains a clinically relevant problem.
Van Poznak C
Cancer J; 2006; 12(1):21-3. PubMed ID: 16613658
[No Abstract] [Full Text] [Related]
4. Zoledronic acid and clodronate in the treatment of malignant bone metastases with hypercalcaemia; efficacy and safety comparative study.
Sabry NA; Habib EE
Med Oncol; 2011 Jun; 28(2):584-90. PubMed ID: 20204542
[TBL] [Abstract][Full Text] [Related]
5. Cisplatin as an active treatment in zoledronate-refractory hypercalcemia.
Lin PH; Chiu CF; Lu YS
Ann Oncol; 2011 May; 22(5):1244-1246. PubMed ID: 21460375
[No Abstract] [Full Text] [Related]
6. [Clinical study of zoledronic acid in the treatment of cancer-induced hypercalcemia].
Shen G; Song ST; Jiang ZF; Bian SG; Xie GR; Wang YJ; Wang JJ
Zhonghua Zhong Liu Za Zhi; 2005 Oct; 27(10):632-4. PubMed ID: 16438878
[TBL] [Abstract][Full Text] [Related]
7. Small cell carcinoma of the urinary bladder with hypercalcemia.
Sendur MA; Aksoy S; Arık Z; Yaman S; Ozdemir NY; Uncu D; Zengin N
Med Oncol; 2012 Jun; 29(2):827-8. PubMed ID: 21499925
[No Abstract] [Full Text] [Related]
8. Hypercalcemia and gallium nitrate.
Gucalp R
J Support Oncol; 2004; 2(6):518-20. PubMed ID: 16329218
[No Abstract] [Full Text] [Related]
9. Treatment of Hypercalcemia of Malignancy.
Chakhtoura M; El-Hajj Fuleihan G
Endocrinol Metab Clin North Am; 2021 Dec; 50(4):781-792. PubMed ID: 34774248
[TBL] [Abstract][Full Text] [Related]
10. Modern management of malignant hypercalcemia.
Legrand SB
Am J Hosp Palliat Care; 2011 Nov; 28(7):515-7. PubMed ID: 21724679
[TBL] [Abstract][Full Text] [Related]
11. The use of zoledronic acid, a novel, highly potent bisphosphonate, for the treatment of hypercalcemia of malignancy.
Major P
Oncologist; 2002; 7(6):481-91. PubMed ID: 12490736
[TBL] [Abstract][Full Text] [Related]
12. Zoledronic acid: a review of its use in the management of bone metastases and hypercalcaemia of malignancy.
Wellington K; Goa KL
Drugs; 2003; 63(4):417-37. PubMed ID: 12558465
[TBL] [Abstract][Full Text] [Related]
13. Chronic Myeloid Leukemia Associated Hypercalcemia: A Case Report and Literature Review.
Toro-Tobón D; Agosto S; Ahmadi S; Koops M; Bruder JM
Am J Case Rep; 2017 Feb; 18():203-207. PubMed ID: 28239141
[TBL] [Abstract][Full Text] [Related]
14. Systemic lupus erythematosus and hypercalcaemia: case report and brief review of the literature.
Karageorgas TP; Avgoustidis N; Ioakeimidis D
Scand J Rheumatol; 2011; 40(5):408-9. PubMed ID: 21916802
[No Abstract] [Full Text] [Related]
15. Impact of chemotherapy on hypercalcemia in breast and lung cancer patients.
Hassan BA; Yusoff ZB; Hassali MA; Othman SB; Weiderpass E
Asian Pac J Cancer Prev; 2012; 13(9):4373-8. PubMed ID: 23167346
[TBL] [Abstract][Full Text] [Related]
16. The use of zoledronic acid in the management of metastatic bone disease and hypercalcaemia.
Neville-Webbe Hl; Coleman RE
Palliat Med; 2003 Sep; 17(6):539-53. PubMed ID: 14526888
[TBL] [Abstract][Full Text] [Related]
17. [The significance of early diagnosis of cancer-related hypercalcaemia].
Radványi I; Csikós A; Balogh S
Orv Hetil; 2013 Sep; 154(35):1367-73. PubMed ID: 23974972
[TBL] [Abstract][Full Text] [Related]
18. A multicenter and open label clinical trial of zoledronic acid 4 mg in patients with hypercalcemia of malignancy.
Kawada K; Minami H; Okabe K; Watanabe T; Inoue K; Sawamura M; Yagi Y; Sasaki T; Takashima S
Jpn J Clin Oncol; 2005 Jan; 35(1):28-33. PubMed ID: 15681601
[TBL] [Abstract][Full Text] [Related]
19. Hypercalcemia of malignancy.
Body JJ
Semin Nephrol; 2004 Jan; 24(1):48-54. PubMed ID: 14730509
[TBL] [Abstract][Full Text] [Related]
20. [Progress in diagnosis and therapy: Hypercalcemia due to multiple myeloma and wide-spread neoplastic bone metastasis].
Abe M
Nihon Naika Gakkai Zasshi; 2007 Apr; 96(4):675-80. PubMed ID: 17506303
[No Abstract] [Full Text] [Related]
[Next] [New Search]